BIO KEY INTERNATIONAL INC
BKYI$3M
Micro CapNASDAQServices-Prepackaged Software🇺🇸North AmericaHOLMDEL
Drugs in Pipeline
4
Phase 3 Programs
3
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
BKYI News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
N1539
Pain, Postoperative
Tinlarebant
Stargardt Disease 1
Roxadustat
CKD Anemia
PRX302
Benign Prostatic Hyperplasia
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
N1539 | Phase 3 | Pain, Postoperative | - | - |
Tinlarebant | Phase 3 | Stargardt Disease 1 | - | - |
Roxadustat | Phase 3 | CKD Anemia | - | - |
PRX302 | Phase 2 | Benign Prostatic Hyperplasia | - | - |
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply